Linden, Joel M.
- Dana-Farber Cancer Institute (no department on record)
From the FY2010 NIH awards this investigator leads as contact PI. The department is the award's.
FY2010 NIH rank #8,770
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2010Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2010
Linked Award Amount
$948.8K
Full award amounts, FY2010
Award Records
1
Records listing this PI
Award-Linked Rank
#8,770
By linked amount among FY2010 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2010 award records by amount
NIH award records listing Linden, Joel M. as a PI. Multi-PI records show the full award amount for context.
- 5RC2HL101367-02RC2Contact PICTRIP: Treatment of Sickle Cell Crisis with inhibitors of NKT cell activation$948.8Kaward amount
Award organization
Organizations that administered FY2010 awards listing Linden, Joel M. as a PI.
FY2010 award administered by Dana-Farber Cancer Institute (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardDana-Farber Cancer Institute
- 2001$500K Cumulative Funding
- 2001Entered Top 50% NationallyRanked #6757
- 2002$1M Cumulative Funding
- 2004$2M Cumulative Funding
- 2004Entered Top 25% NationallyRanked #1350
- 2004Entered Top 10% NationallyRanked #1350
- 2005$5M Cumulative Funding